Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pat Furlong

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Journal of Neuromuscular Diseases|November 19, 2023
Moving Beyond the 2018 Minimum International Care Considerations for Osteoporosis Management in Duchenne Muscular Dystrophy (DMD): Meeting Report from the 3rd International Muscle-Bone Interactions Meeting 7th and 14th November 2022Kim Phung, Nicola Crabtree, Anne M Connolly, et al.
Lancet (London, England)|March 13, 2022
Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialCraig M McDonald, Eduardo Marbán, Suzanne Hendrix, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2015
Large-scale serum protein biomarker discovery in Duchenne muscular dystrophyYetrib Hathout, Edward Brody, Paula R Clemens, et al.
The Lancet. Neurology|June 16, 2016
Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophyVolker Straub, Pavel Balabanov, Kate Bushby, et al.
Scientific Reports|November 29, 2024
Evidentiary basis of the first regulatory qualification of a digital primary efficacy endpointLaurent Servais, Paul Strijbos, Margaux Poleur, et al.
Plos Currents|February 24, 2017
Duchenne Regulatory Science Consortium Meeting on Disease Progression Modeling for Duchenne Muscular DystrophyJane Larkindale, Richard Abresch, Enrique Aviles, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Journal of Neuromuscular Diseases|November 19, 2023
Moving Beyond the 2018 Minimum International Care Considerations for Osteoporosis Management in Duchenne Muscular Dystrophy (DMD): Meeting Report from the 3rd International Muscle-Bone Interactions Meeting 7th and 14th November 2022Kim Phung, Nicola Crabtree, Anne M Connolly, et al.
Lancet (London, England)|March 13, 2022
Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialCraig M McDonald, Eduardo Marbán, Suzanne Hendrix, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2015
Large-scale serum protein biomarker discovery in Duchenne muscular dystrophyYetrib Hathout, Edward Brody, Paula R Clemens, et al.
The Lancet. Neurology|June 16, 2016
Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophyVolker Straub, Pavel Balabanov, Kate Bushby, et al.
Scientific Reports|November 29, 2024
Evidentiary basis of the first regulatory qualification of a digital primary efficacy endpointLaurent Servais, Paul Strijbos, Margaux Poleur, et al.
Plos Currents|February 24, 2017
Duchenne Regulatory Science Consortium Meeting on Disease Progression Modeling for Duchenne Muscular DystrophyJane Larkindale, Richard Abresch, Enrique Aviles, et al.
Pageof 3